FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1495581000168106: List of Medicines for Brand Consideration reference set (foundation metadata concept)

Status: current, Primitive. Date: 30-Sep 2020. Module: Third party reference set module

Descriptions:

Id Description Lang Type Status Case? Module
4462321000168116 List of Medicines for Brand Consideration reference set (foundation metadata concept) en Fully specified name Active Initial character case insensitive Third party reference set module
4462331000168118 List of Medicines for Brand Consideration reference set en Synonym Active Initial character case insensitive Third party reference set module
4462411000168119 List of Medicines for Brand Consideration (LMBC) reference set en Synonym Active Initial character case insensitive Third party reference set module
4462641000168118 <p>Supports the identification of AMT Medicinal Product Unit of Use (MPUU) and Medicinal Product Pack (MPP) concepts associated with the List of Medicines for Brand Consideration (LMBC) that forms part of the Active Ingredient Prescribing initiative. Under the <i>National Health (Pharmaceutical Benefits) Regulations 2017</i>, the <i>Repatriation Pharmaceutical Benefits Scheme Instrument 2013</i> and <i>MRCA Pharmaceutical Benefits Scheme Instrument 2013</i>, all PBS and RPBS prescriptions must be prepared by active ingredient, the brand may additionally be identified if a prescriber considers it necessary. The LMBC supports prescribers' decision-making regarding the inclusion of brand on a prescription.</p><p>This reference set can be used by prescribing software vendors to identify medications for brand consideration to meet Active Ingredient Prescribing requirements.</p><p><b>Target Client:&nbsp;</b>This reference set was developed by the National Clinical Terminology Service for the Australian Government Department of Health and Aged Care to support the Active Ingredient Prescribing initiative, and can be used by developers to assist with the requirements.</p> en Definition Active Case sensitive Third party reference set module

1324 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
List of Medicines for Brand Consideration reference set Is a Reference sets for Medications true Inferred relationship Some
List of Medicines for Brand Consideration reference set Is a Simple type reference set true Inferred relationship Some
List of Medicines for Brand Consideration reference set Developed by Australian Government Department of Health and Aged Care true Inferred relationship Some 1570063879
Members
somatropin 1.4 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 1.6 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 1.6 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 1.8 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 1.8 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 2 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 2 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 400 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 400 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 600 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 600 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 800 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 800 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
leuprorelin acetate 7.5 mg modified release injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber syringe
methylprednisolone 40 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber vial
methylprednisolone 40 mg injection [1 chamber] (&) inert substance diluent [1 x 1 mL chamber], 5 dual chamber vials
somatropin 12 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber cartridge
somatropin 12 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device
somatropin 12 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 5 dual chamber pen devices
somatropin 5 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber cartridge
somatropin 5 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device
somatropin 5 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 5 dual chamber pen devices
leuprorelin acetate 22.5 mg modified release injection [1 chamber] (&) inert substance diluent [1.5 mL chamber], 1 dual chamber syringe
leuprorelin acetate 30 mg modified release injection [1 chamber] (&) inert substance diluent [1.5 mL chamber], 1 dual chamber syringe
leuprorelin acetate 45 mg modified release injection [1 chamber] (&) inert substance diluent [1.5 mL chamber], 1 dual chamber syringe
somatropin 12 mg injection [1 cartridge] (&) inert substance diluent [3.15 mL syringe], 1 pack
somatropin 24 mg injection [1 cartridge] (&) inert substance diluent [3.15 mL syringe], 1 pack
somatropin 6 mg injection [1 cartridge] (&) inert substance diluent [3.17 mL syringe], 1 pack
interferon beta-1a 6 million units (30 microgram) injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack
interferon beta-1a 6 million units (30 microgram) injection [4 vials] (&) inert substance diluent [4 x 1.1 mL syringes], 1 pack
norethisterone 1 mg + mestranol 50 microgram tablet [21] (&) inert substance tablet [7], 28
norethisterone 1 mg + mestranol 50 microgram tablet [21] (&) inert substance tablet [7], 4 x 28
insulin aspart 100 units/mL injection, 1 x 10 mL vial
insulin aspart 100 units/mL injection, 3 mL pen device
insulin aspart 100 units/mL injection, 10 x 3 mL cartridges
insulin aspart 100 units/mL injection, 10 x 3 mL pen devices
insulin aspart 100 units/mL injection, pen device
insulin aspart 100 units/mL injection, 5 x 10 mL vials
insulin aspart 100 units/mL injection, 5 x 3 mL cartridges
insulin aspart 100 units/mL injection, 5 x 3 mL pen devices
insulin aspart 100 units/mL injection, cartridge
insulin aspart 100 units/mL injection, vial
insulin aspart 30 units/mL + insulin aspart protamine 70 units/mL pen device
insulin aspart 30 units/mL + insulin aspart protamine 70 units/mL injection, 5 x 3 mL cartridges
insulin aspart 30 units/mL + insulin aspart protamine 70 units/mL injection, 5 x 3 mL pen devices
insulin aspart 30 units/mL + insulin aspart protamine 70 units/mL injection, cartridge
insulin degludec 70 units/mL + insulin aspart 30 units/mL injection, 3 mL pen device
insulin degludec 70 units/mL + insulin aspart 30 units/mL injection, 3 mL cartridge
insulin degludec 70 units/mL + insulin aspart 30 units/mL injection, 3 mL pen device
insulin aspart 30 international units / 1 mL + insulin degludec 70 international units / 1 mL injection, 5 x 3 mL cartridges (medicinal product pack)
insulin degludec 70 units/mL + insulin aspart 30 units/mL injection, 5 x 3 mL pen devices
insulin aspart 50 units/mL + insulin aspart protamine 50 units/mL injection, cartridge
insulin aspart 50 units/mL + insulin aspart protamine 50 units/mL injection, pen device
insulin aspart 50 units/mL + insulin aspart protamine 50 units/mL injection, 5 x 3 mL cartridges
insulin aspart 50 units/mL + insulin aspart protamine 50 units/mL injection, 5 x 3 mL pen devices
insulin aspart 70 units/mL + insulin aspart protamine 30 units/mL injection, cartridge
insulin aspart 70 units/mL + insulin aspart protamine 30 units/mL injection, pen device
insulin aspart 70 units/mL + insulin aspart protamine 30 units/mL injection, 5 x 3 mL cartridges
insulin aspart 70 units/mL + insulin aspart protamine 30 units/mL injection, 5 x 3 mL pen devices
insulin degludec 100 units/mL + liraglutide 3.6 mg/mL injection, 3 mL pen device
insulin degludec 100 units/mL + liraglutide 3.6 mg/mL injection, 3 mL pen device
insulin degludec 100 units/mL + liraglutide 3.6 mg/mL injection, 3 x 3 mL pen devices
insulin degludec 100 units/mL + liraglutide 3.6 mg/mL injection, 5 x 3 mL pen devices
insulin degludec 100 units/mL injection, 3 mL pen device
insulin degludec 100 units/mL injection, cartridge
insulin degludec 100 units/mL injection, 3 mL pen device
insulin degludec 100 units/mL injection, 5 x 3 mL cartridges
insulin degludec 100 units/mL injection, 5 x 3 mL pen devices
insulin degludec 200 units/mL injection, 3 mL pen device
insulin degludec 200 units/mL injection, 3 mL pen device
insulin degludec 200 units/mL injection, 3 x 3 mL pen devices
insulin detemir 100 units/mL injection, 3 mL pen device
insulin detemir 100 units/mL injection, 5 x 3 mL cartridges
insulin detemir 100 units/mL injection, 5 x 3 mL pen devices
insulin detemir 100 units/mL injection, cartridge
insulin glargine 100 units/mL + lixisenatide 33 microgram/mL injection, 3 mL pen device
insulin glargine 100 units/mL + lixisenatide 33 microgram/mL injection, pen device
insulin glargine 100 units/mL + lixisenatide 33 microgram/mL injection, 3 x 3 mL pen devices
insulin glargine 100 units/mL + lixisenatide 33 microgram/mL injection, 5 x 3 mL pen devices
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 3 mL pen device
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 3 x 3 mL pen devices
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 5 x 3 mL pen devices
insulin glargine 100 units/mL injection, 1 x 10 mL vial
insulin glargine 100 units/mL injection, 3 mL cartridge
insulin glargine 100 units/mL injection, 3 mL pen device
insulin glargine 100 units/mL injection, 10 x 3 mL cartridges
insulin glargine 100 units/mL injection, 10 x 3 mL pen devices
insulin glargine 100 units/mL injection, 2 x 3 mL cartridges
insulin glargine 100 units/mL injection, 2 x 3 mL pen devices
insulin glargine 100 units/mL injection, 3 mL pen device
insulin glargine 100 units/mL injection, 5 x 3 mL cartridges
insulin glargine 100 units/mL injection, 5 x 3 mL pen devices
insulin glargine 100 units/mL injection, cartridge
insulin glargine 100 units/mL injection, vial
insulin glargine 300 units/mL injection, 1.5 mL pen device
insulin glargine 300 units/mL injection, 3 mL pen device
insulin glargine 300 units/mL injection, pen device
insulin glargine 300 units/mL injection, 3 mL pen device
insulin glargine 300 units/mL injection, 3 x 1.5 mL pen devices
insulin glargine 300 units/mL injection, 3 x 3 mL pen devices

Start Previous Page 8 of 14 Next End

Reference Sets

Australian dialect reference set

Reference set descriptor

Back to Start